3 Wall Street Analysts Think Viking Therapeutics Stock Will Roughly Triple Over the Next 12 Months. Here's Why I Think They're Wrong
Viking Therapeutics deserves a second look, but some analysts are a bit too optimistic.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
